24 results match your criteria: "Makerere University-John Hopkins University Research Collaboration[Affiliation]"

Background: Preexposure prophylaxis (PrEP) reduces new human immunodeficiency virus(HIV) infections by up to 96% and is recommended for key populations by the World Health Organization. Understanding the knowledge and willingness to use PrEP is essential for effective implementation. This study assessed these factors and identifiedcharacteristics associated with differences in knowledge among key populations in Kampala, Uganda.

View Article and Find Full Text PDF

Poor neurodevelopment, nutritional and physical growth outcomes among children born to mothers with nodding syndrome.

Seizure

September 2024

College of Health Sciences, Makerere University, P.O. Box 7072, Kampala-Uganda; Global Health Uganda, P.O. Box 33842, Kampala-Uganda; Centre of Tropical Neuroscience, Kitgum Site, P.O. Box 27520, Kampala-Uganda.

Introduction: Nodding syndrome (NS), a poorly understood severe neurological disorder develops in children. In Uganda, some NS cases have grown into child-bearing adults. Babies born to mothers with NS may be prone to impaired neurodevelopmental outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • - VESTED (NCT03048422) compared the safety and effectiveness of three antiretroviral therapy regimens in pregnant and postpartum women with HIV, finding a low vertical transmission rate of 0.60% among infants.
  • - The study analyzed data from 2018 to 2020, enrolling women in early pregnancy and measuring outcomes up to 50 weeks postpartum, focusing on HIV drug resistance in cases of transmission.
  • - Results revealed that mothers taking efavirenz-based treatment prior to switching to dolutegravir likely contributed to the transmission of specific HIV drug resistance mutations to their infants, despite prophylactic treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Product adherence significantly impacts the accurate evaluation of HIV-1 prevention methods like the dapivirine vaginal ring, with varying levels of adherence leading to biased efficacy estimates.* -
  • In the MTN-020/ASPIRE trial, per-protocol analyses indicated a 30.8% efficacy, while those with the highest adherence showed an efficacy of 53.6% when analyzing drug release from the ring.* -
  • Advanced statistical methods, such as principal stratification and marginal structural models, enhance our understanding of HIV-1 prevention effectiveness in clinical trials by adjusting for adherence levels.*
View Article and Find Full Text PDF

Objectives: The aim of this study was to determine the prevalence of pelvic floor disorders (PFDs) and associated risk factors among parous Ugandan women.

Methods: We performed a cross-sectional study of parous Ugandan women. Demographics and assessment for PFD were obtained.

View Article and Find Full Text PDF

Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites.

J Infect Dis

December 2024

Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis.

Background: We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women with human immunodeficiency virus (HIV). Here we explored the role of cervicovaginal cytokines and drug metabolizing enzymes and transporters (DMETs) to elucidate female genital tract (FGT) drug disposition in a Ugandan cohort.

Methods: Cervicovaginal fluid and cervical biopsies were collected from Ugandan women with HIV receiving tenofovir/lamivudine-based therapy and intramuscular depot medroxyprogesterone acetate (n = 25), copper intrauterine device (cuIUD; n = 12), or condoms (n = 13) as contraception.

View Article and Find Full Text PDF

Background: In children with severe acute malnutrition (SAM) tuberculosis is common, challenging to diagnose, and often fatal. We developed tuberculosis treatment decision algorithms (TDAs) for children under the age of 5 years with SAM.

Methods: In this prospective diagnostic study, we enrolled and followed up children aged <60 months hospitalised with SAM at three tertiary hospitals in Zambia and Uganda from 4 November 2019 to 20 June 2022.

View Article and Find Full Text PDF

Introduction And Hypothesis: The aim was to assess the association between the degree of physical activity (PA) and the presence of pelvic floor disorders (PFDs) in a cohort of parous Ugandan women.

Methods: In this cross-sectional study, PFDs were measured using symptom assessment, standardized questionnaires (Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire), and a standardized physical examination (POP-Q and cough stress test [CST]). Degree of PA was assessed using the International Physical Activity Questionnaire.

View Article and Find Full Text PDF

Reliability and Validation of the PFIQ-7 and PFDI-20 in the Luganda Language.

Int Urogynecol J

August 2024

Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Drive 31674 PFP, Iowa City, IA, 52242, USA.

Introduction And Hypothesis: Pelvic floor disorders (PFDs) impact women worldwide and are assessed using instruments such as the Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Floor Impact Questionnaire (PFIQ-7). There are no known valid PFD instruments in Uganda. This study's purpose was to translate and test the reliability and validity of the PFDI-20 and PFIQ-7 in Luganda.

View Article and Find Full Text PDF

Background: The involvement of pregnant women in vaccine clinical trials presents unique challenges for the informed consent process. We explored the expectations and experiences of the pregnant women, spouses/partners, health workers and stakeholders of the consent process during a Group B Streptococcus maternal vaccine trial.

Methods: We interviewed 56 participants including pregnant women taking part in the trial, women not in the trial, health workers handling the trial procedures, spouses, and community stakeholders.

View Article and Find Full Text PDF

Background: Dolutegravir (DTG)-based antiretroviral therapy (ART) is currently the preferred first-line treatment for persons living with HIV (PLHIV) including children and adolescents in many low- and middle-income countries including Uganda. However, there are concerns about excessive weight gain associated with DTG especially in adults. There remains paucity of current information on weight-related outcomes among adolescents on DTG.

View Article and Find Full Text PDF

Objective: HIV treatment regimen during pregnancy was associated with preterm delivery (PTD) in the PROMISE 1077 BF trial. Systemic inflammation among pregnant women with HIV could help explain differences in PTD by treatment regimen. We assessed associations between inflammation, treatment regimen, and PTD.

View Article and Find Full Text PDF
Article Synopsis
  • - This analysis focused on postpartum women undergoing HIV treatment to explore the prevalence and risk factors for neurocognitive toxicity, particularly in relation to the interaction between Isoniazid Preventive Therapy (IPT) and Efavirenz.
  • - Involving 956 women, the study evaluated depression, cognitive function, sleep quality, and peripheral neuropathy at various postpartum weeks, revealing peaks of mild depression (13%), cognitive complaints (8%), and poor sleep quality (10%) at 12 weeks.
  • - Results indicated no significant differences in neurotoxic symptom odds based on the timing of IPT initiation or use of Efavirenz, suggesting the need for further investigation into neurotoxicity risk factors.
View Article and Find Full Text PDF

Introduction: Optimal adherence to antiretroviral therapy (ART) is crucial to promoting maternal-infant health.

Setting: Fourteen sites in 7 countries within sub-Saharan Africa and India.

Methods: The multicomponent, open-label strategy PROMISE trial enrolled breastfeeding mother-infant pairs not meeting in-country criteria for maternal ART (mART) initiation in the postpartum component within 5 days of delivery.

View Article and Find Full Text PDF

The effect of smoking on immune responses in people with tuberculosis (TB) is not well elucidated. We aimed to compare peripheral blood counts of CD4+ and CD87 + T-lymphocytes, monocytes, and neutrophils and the CD4:CD8 ratio in TB patients with and without history of cigarette smoking. We further determined factors associated with current smoking.

View Article and Find Full Text PDF

Background: The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%.

View Article and Find Full Text PDF

Background: Surveillance programs in low- and middle-income countries (LMICs) have difficulty in obtaining accurate information about congenital anomalies.

Methods: As part of the ZikaPLAN project, an International Committee developed an app for the description and coding of congenital anomalies that are externally visible at birth, for use in low resource settings. The "basic" version of the app was designed for a basic clinical setting and to overcome language and terminology barriers by providing diagrams and photos, sourced mainly from international Birth Defects Atlases.

View Article and Find Full Text PDF

Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding.

J Acquir Immune Defic Syndr

April 2021

Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.

IMPAACT PROMISE 1077BF/FF was a sequentially randomized study of pregnant and postpartum women living with HIV to investigate the efficacy and safety of antiretroviral therapy (ART). This Maternal Health Component investigated efficacy for the risk of developing AIDS or death; and safety among women randomized to continue ART (CTART: N = 289) or discontinue ART (N = 268) after cessation of breastfeeding or after confirmation of infant infection. No AIDS-defining illnesses were reported during follow-up in either arm.

View Article and Find Full Text PDF

Background: Given well documented challenges faced by pregnant women living with HIV taking lifetime ART, it is critical to understand the impact of short-term ART exposure followed by treatment interruption on maternal health outcomes.

Methods: HIV+ breastfeeding (BF) and Formula Feeding (FF) women with CD4 counts > 350 cells/mm3, enrolled in the 1077BF/1077FF PROMISE trial were followed to assess the effect of ART during pregnancy and breastfeeding respectively. The first analysis compared ART use limited to the antepartum period (AP-only) relative to women randomized to Zidovudine.

View Article and Find Full Text PDF

Background: Acceptability of Pre-exposure Prophylaxis (PrEP) could be hampered by low self-perceived risk for HIV acquisition. Moreover, discordance between risk perception and actual risk of HIV acquisition is likely to occur. We assessed congruence between the level of self- perceived and that of objectively scored risk of HIV acquisition among HIV-negative individuals in discordant relationships.

View Article and Find Full Text PDF

Background: Preterm infants are at increased risk of infections including vaccine preventable diseases. Therefore, timely vaccination is crucial to ensure adequate disease protection. Information on whether preterm infants are vaccinated according to chronological age as recommended is limited in low-income countries.

View Article and Find Full Text PDF

Background: Effective concentrations of antiretrovirals in the female genital tract (FGT) are critical for suppression of viral shedding or effective preexposure prophylaxis. The disposition of tenofovir diphosphate (TFV-DP) and emtricitabine triphosphate (FTC-TP) in the FGT have been previously described. Despite widespread use, however, lamivudine triphosphate (3TC-TP) exposure in the FGT is unknown.

View Article and Find Full Text PDF

Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.

J Acquir Immune Defic Syndr

November 2017

*Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA; †University of Washington, Seattle, WA; ‡Johns Hopkins University School of Medicine, Baltimore, MD; §Magee-Womens Research Institute & Foundation, University of Pittsburgh Medical Center, Pittsburgh, PA; ‖Wits Reproductive Health and HIV Institute, University of Witwatersrand, Hillbrow Health Precinct, Johannesburg, South Africa; ¶Makerere University-John Hopkins University Research Collaboration, Kampala, Uganda; #Center for AIDS Programme of Research in South Africa, Durban, South Africa; **Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health Rockville, MD; ††FHI 360, Durham, NC; and ‡‡Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA.

Background: Placebo-controlled HIV-1 prevention trials of pre-exposure prophylaxis (PrEP) have not generally used concurrent measurement of adherence because of the potential risk of unblinding. However, several pre-exposure prophylaxis trials for HIV-1 prevention among women failed to show effectiveness because of low product adherence. Evaluation of product adherence objectively during a study provides the opportunity for strengthening adherence activities at sites having low adherence.

View Article and Find Full Text PDF

Background: Dietary intake is a known determinant of body mass index (BMI) among different populations and is therefore a useful component for BMI control. To our knowledge, no study has investigated the usual dietary intake and its association with BMI in type 2 diabetes patients among the Ugandan population. This study aimed to analyse the usual dietary intake of newly diagnosed type 2 diabetes patients and determine the association between the different dietary nutrients and BMI.

View Article and Find Full Text PDF